Clinical Trial

Safety and Efficacy of the Hydrophobic Intraocular Lens Asqelio Monofocal With Biaspheric Design

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to learn about the Asqelio monofocal intraocular lens (IOL) model QLIO130C in patients undergoing cataract surgery. The aim of the study is to evaluate the lens implementation safety and efficacy after at least 24 months.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-20; most recent amendment 2024-10-04.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-10-04
Trial Details
NCT Number NCT06056154
Lead Sponsor AST Products, Inc.
Conditions Cataract, Pseudophakia
Enrollment 150 participants
Start Date 2024-01-17
Primary Completion 2025-05 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-10-08